Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $116.1500 (-3.64%) ($116.1400 - $116.1500) on Wed. Mar. 30, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.58% (three month average) | RSI | 61 | Latest Price | $116.1500(-3.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.1% a day on average for past five trading days. | Weekly Trend | LGND advances 5.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(60%) IWM(59%) IWC(56%) IWN(56%) | Factors Impacting LGND price | LGND will decline at least -1.79% in a week (0% probabilities). VIXM(-25%) UUP(-20%) VXX(-16%) TBT(-7%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.79% (StdDev 3.58%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $116.27(-0.1%) | 10 Day Moving Average | $113.96(1.92%) | 20 Day Moving Average | $108.61(6.94%) | To recent high | -25.9% | To recent low | 21.8% | Market Cap | $1.867b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |